In Vitro Toxicology Testing Market : Emerging Market Trends, Top Growing Segments and Future Developments
According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.
The
major factors driving the growth of this market are the opposition to
animal testing, technological advancements, and increasing R&D
expenditure to detect toxicity at an early stage during drug development
are the primary growth drivers for this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065
By
product and service, the consumables segment is expected to account for
the largest share of the in vitro toxicology testing market
The
consumables segment is estimated to account for the largest market share
in 2019. The large share of this segment can be attributed to the
increasing demand for high-quality reagents and the repeated use of
media and reagents in in vitro toxicology studies.
In the
toxicity endpoints and tests market, the organ toxicity segment is
expected to grow at the highest CAGR during the forecast period
The
organ toxicity segment is expected to grow at the highest CAGR during
the forecast period. The growth in this segment can be attributed to
factors such as the increasing focus on drug safety and consumer-product
safety, along with the need to screen potential drug targets during the
early stage of drug development.
Based on the technologies used
in the in vitro toxicology testing, the cell culture technologies
segment is expected to account for the largest share of the in vitro
toxicology testing market
The cell culture technologies segment
is estimated to account for the largest market share in 2018. The large
share of this segment can be attributed to the fact that it is the most
preferred technique for toxicity testing, being capable of mimicking in
vivo conditions.
Thermo Fisher Scientific Inc. (US), Covance
(US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins
Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River
Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex
(UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation
(US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories
(US) are some key players in this market. These companies are focusing
on increasing their presence in the high-growth markets through both
organic as well as inorganic growth strategies such as product launches,
acquisitions, and expansions.
Thermo Fisher Scientific was one
of the leading players in the in vitro toxicology testing market in
2019. The company is a global manufacturer of analytical instruments,
laboratory equipment, software, consumables, reagents, and services for
the in vitro toxicology testing market. Owing to its strong sales and
distribution network, the company has a significant global footprint.
The company leverages the advantage of three well-established
brands—Thermo Scientific, Fisher Scientific, and Unity Lab Services. In
February 2014, Thermo Fisher acquired Life Technologies (US), thereby
adding another brand name to its business. Under the four brands
mentioned above, the company has a very strong product portfolio for
instruments, reagents, and services for life science research.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065
The APAC in vitro toxicology testing market
is projected to register the highest growth during the forecast period.
Factors such as emergence of CROs for outsourcing toxicology-related
research projects, opposition to animal testing resulting in the use of
alternate methods, increasing pharmaceutical drug pipeline, and growing
consumer awareness of product safety are some of the key factors driving
the growth of the market in the APAC.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com